Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil Dong-Hyun ChoiWan-Gyun ShinJun-Shik Choi Clinical Trial 12 January 2008 Pages: 445 - 449
A nurse-led intervention for identification of drug-related problems Monica BergqvistJohanna UlfvarsonChrister von Bahr Special Article 19 January 2008 Pages: 451 - 456
The effect on heart rate of combining single-dose fingolimod with steady-state atenolol or diltiazem in healthy subjects John M. KovarikMichael LuRobert L. Schmouder Pharmacodynamics 15 January 2008 Pages: 457 - 463
The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangements Andrea GaedigkChrista Coetsee Pharmacogenetics 17 January 2008 Pages: 465 - 475
Further evidence for the association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients Arzu GunesMarja-Liisa DahlMaria Gabriella Scordo Pharmacogenetics 18 January 2008 Pages: 477 - 482
Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele M. HermannM. HendsetH. Refsum Pharmacogenetics 23 January 2008 Pages: 483 - 487
Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients Anna FerrariDiego PinettiEmilio Sternieri Pharmacokinetics and Disposition 08 January 2008 Pages: 489 - 495
Early pharmacokinetics of nasal fentanyl: is there a significant arterio-venous difference? Kristin MoksnesOlav M. FredheimOla Dale Pharmacokinetics and Disposition 06 January 2008 Pages: 497 - 502
Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers Takenori NiiokaMasatomo MiuraToshio Suzuki Pharmacokinetics and Disposition 26 January 2008 Pages: 503 - 509
Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo Marjo J. KarjalainenPertti J. NeuvonenJanne T. Backman Pharmacokinetics and Disposition 16 January 2008 Pages: 511 - 519
Modelling ocular pharmacokinetics of fluorescein administered as lyophilisate or conventional eye drops Khaled AbduljalilMichael DiestelhorstUwe Fuhr Pharmacokinetics and Disposition 25 January 2008 Pages: 521 - 529
The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports Hieronymus J. DerijksRonald H. B. MeyboomAntoine C. G. Egberts Pharmacoepidemiology and Prescription Open access 15 January 2008 Pages: 531 - 538
Ten years after the Dutch public health campaign on folic acid: the continuing challenge Hermien E. K. de WalleLolkje T. W. de Jong-van den Berg Pharmacoepidemiology and Prescription Open access 22 January 2008 Pages: 539 - 543
Predictors of orphan drug approval in the European Union Harald E. HeemstraRemco L. de VruehHubert G. M. Leufkens Pharmacoepidemiology and Prescription Open access 22 January 2008 Pages: 545 - 552
Detection of the pharmaceutical agent glaucine as a recreational drug Paul I. DarganJenny ButtonDavid M. Wood Letter to the Editors 16 January 2008 Pages: 553 - 554